Skip to main content
Clinical Trials/PACTR202310525672884
PACTR202310525672884
Not yet recruiting
Phase 4

Analgesic effectiveness of wound infiltration with bupivacaine and a mixture of bupivacaine and tramadol for postoperative pain management among participants undergoing elective cesarean section under spinal anesthesia at Dilla university general hospital, 2023: a double-blind randomized controlled trial

Dilla University0 sites60 target enrollmentSeptember 19, 2023

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Fertility-female
Sponsor
Dilla University
Enrollment
60
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
September 19, 2023
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
Female

Investigators

Eligibility Criteria

Inclusion Criteria

  • ?Pregnant mothers between 18 and 45
  • ?ASA class \=II

Exclusion Criteria

  • ?Patients with known allergies to bupivacaine and tramadol
  • ?History of alcohol usage, opiate or other drug abuse
  • ?Pregnant mothers who diagnosed with Chronic pain
  • ?Pregnant mothers with systemic diseases like renal impairment, chronic liver disease, chronic obstructive pulmonary disease, and cardiac disease
  • ?Pregnant mothers with pre\-eclampsia, eclampsia
  • ?Spinal anesthesia with adjuvants
  • ?Operation other than the lower uterine segment incision
  • ?Pregnant mothers taking opioids preoperatively

Outcomes

Primary Outcomes

Not specified

Similar Trials